Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey

BACKGROUND: All international guidelines suggested that Tenofovir and Entecavir are the primary drugs at the first line therapy for the treatment of chronic hepatitis B (CHB). However, in Turkey these medications reimbursed at the second line therapy according to the Healthcare Implementation Notifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kockaya, Guvenc, Kose, Akin, Yenilmez, Fatma Betul, Ozdemir, Oktay, Kucuksayrac, Ece
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674927/
https://www.ncbi.nlm.nih.gov/pubmed/26664289
http://dx.doi.org/10.1186/s12962-015-0046-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674927/
https://www.ncbi.nlm.nih.gov/pubmed/26664289
http://dx.doi.org/10.1186/s12962-015-0046-8

Ejemplares similares